INSULATARD Side Effects

7014558-X | Anaemia Macrocytic, Depressed Level Of Consciousness, Hypoglycaemia, Lactic Acidosis, Overdose, Renal Failure Acute, Vitamin B12 Deficiency
on Sep 14, 2010 Female patient from FRANCE , 72 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Insulatard (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia macrocytic, depressed level of consciousness, hypoglycaemia, lactic acidosis, overdose, renal failure acute, vitamin b12 deficiency. Insulatard dosage: Uk/sc. During the same period patient was treated with METFORMIN (Unk) (View Metformin Review and Metformin Label ), TRIATEC /00116401/ (Unk) (View Triatec /00116401/ Review and Triatec /00116401/ Label ), ISOPTIN (Unk) (View Isoptin Review and Isoptin Label ). Patient was hospitalized.

6930350-6 | Caudal Regression Syndrome, Spinal Column Stenosis
Patient was taking Insulatard (View Usage). Patient had the following side effects: caudal regression syndrome, spinal column stenosis on Aug 06, 2010 from IRELAND Additional patient health information: Male patient , weighting 8.18 lb, was diagnosed with type 1 diabetes mellitus and. Insulatard dosage: . During the same period patient was treated with NOVORAPID (View Novorapid Review and Novorapid Label ).

6781334-2 | Dermatitis Exfoliative, Eyelid Oedema, Rash Macular, Rash Pustular, Skin Exfoliation
Adverse event was reported on Jun 09, 2010 by a Male patient taking Insulatard (View Usage) (Dosage: Uk/sc) was diagnosed with type 2 diabetes mellitus and. Location: FRANCE , 65 years of age, After Insulatard was administered, patient had the following side effects: dermatitis exfoliative, eyelid oedema, rash macular, rash pustular, skin exfoliation. During the same period patient was treated with ALDACTONE (Unk) (View Aldactone Review and Aldactone Label ), ALLOPURINOL (300 Mg, Qd) (View Allopurinol Review and Allopurinol Label ), CHONDROSULF (Unk) (View Chondrosulf Review and Chondrosulf Label ), DIFFU K (View Diffu K Review and Diffu K Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), TAHOR (View Tahor Review and Tahor Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ), RILMENIDINE (View Rilmenidine Review and Rilmenidine Label ). Patient was hospitalized.

6743444-5 | Hyperhidrosis, Hypoglycaemia, Locked-in Syndrome
on May 17, 2010 Female patient from FRANCE , 82 years of age, weighting 134.5 lb, was diagnosed with type 2 diabetes mellitus, hypertension and was treated with Insulatard (View Usage). Patient experienced the following unwanted or unexpected effects: hyperhidrosis, hypoglycaemia, locked-in syndrome. Insulatard dosage: 60 Iu Morning And 8 Iu Evening, Qd. During the same period patient was treated with NOVONORM (1 Mg, Qd) (View Novonorm Review and Novonorm Label ), STAGID (700 Mg, Noon, Qd) (View Stagid Review and Stagid Label ), DETENSIEL /00802602/ (10 Mg Morning, Qd) (View Detensiel /00802602/ Review and Detensiel /00802602/ Label ), UVEDOSE (100,000 Iu, Every 15 Days) (View Uvedose Review and Uvedose Label ), TAHOR (10 Mg, Qd) (View Tahor Review and Tahor Label ), PLAVIX (Film-coated Tablet) (View Plavix Review and Plavix Label ), INEXIUM /01479302/ (Gastro-resistant Tab) (View Inexium /01479302/ Review and Inexium /01479302/ Label ), DOLIPRANE (500 Mg) (View Doliprane Review and Doliprane Label ). Patient was hospitalized.


6690963-6 | Hyperhidrosis, Hypoglycaemia, Locked-in Syndrome
on Apr 14, 2010 Female patient from FRANCE , 82 years of age, was diagnosed with type 2 diabetes mellitus, hypertension and was treated with Insulatard (View Usage). Patient had the following side effects: hyperhidrosis, hypoglycaemia, locked-in syndrome. Insulatard dosage: 60 Iu Morning And 8 Iu Evening, Qd. During the same period patient was treated with NOVONORM (1 Mg, Qd) (View Novonorm Review and Novonorm Label ), STAGID (700 Mg, Noon, Qd) (View Stagid Review and Stagid Label ), DETENSIEL /00802602/ (10 Mg Morning, Qd) (View Detensiel /00802602/ Review and Detensiel /00802602/ Label ), UVEDOSE (100 000 Iu, Drinkable Sol) (View Uvedose Review and Uvedose Label ), TAHOR (10 Mg, Unk) (View Tahor Review and Tahor Label ), PLAVIX (Film-coated Tablet) (View Plavix Review and Plavix Label ), INEXIUM /01479302/ (Gastro-resistant Tab) (View Inexium /01479302/ Review and Inexium /01479302/ Label ). Patient was hospitalized.

6689085-X | Gangrene
Patient was taking Insulatard (View Usage). After Insulatard was administered, patient had the following side effects: gangrene on Apr 09, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 46 years of age, was diagnosed with type 1 diabetes mellitus and. Insulatard dosage: . During the same period patient was treated with HUMULIN S (Unk) (View Humulin S Review and Humulin S Label ). Patient was hospitalized.

6657230-8 | Blood Glucose Fluctuation, Hypoglycaemia, Hypoglycaemic Coma, Intentional Overdose, Suicide Attempt
Adverse event was reported on Mar 24, 2010 by a Female patient taking Insulatard (View Usage) (Dosage: 100 Iu, Single) . Location: CZECH REPUBLIC , 56 years of age, Patient experienced the following unwanted or unexpected effects: blood glucose fluctuation, hypoglycaemia, hypoglycaemic coma, intentional overdose, suicide attempt. Patient was hospitalized.

6569588-9 | Hypoglycaemic Coma, Intentional Overdose, Suicide Attempt
on Jan 27, 2010 Female patient from CZECH REPUBLIC , 56 years of age, was treated with Insulatard (View Usage). Patient had the following side effects: hypoglycaemic coma, intentional overdose, suicide attempt. Insulatard dosage: 100 Iu, Single. Patient was hospitalized.

6555491-7 | Injection Site Abscess
on Jan 21, 2010 Female patient from UNITED KINGDOM , weighting 158.7 lb, was diagnosed with type 1 diabetes mellitus and was treated with Insulatard (View Usage). After Insulatard was administered, patient had the following side effects: injection site abscess. Insulatard dosage: Unk. During the same period patient was treated with NOVORAPID (Unk) (View Novorapid Review and Novorapid Label ). Patient was hospitalized.

6528181-4 | Hypoglycaemic Coma, Intentional Overdose, Suicide Attempt
Patient was taking Insulatard (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemic coma, intentional overdose, suicide attempt on Dec 28, 2009 from CZECH REPUBLIC Additional patient health information: Female patient , 56 years of age, . Insulatard dosage: 100 Iu, Single. Patient was hospitalized.

6441073-4 | Convulsion, Hypoglycaemia, Muscle Spasms, Product Quality Issue, Respiratory Distress
Adverse event was reported on Nov 05, 2009 by a Female patient taking Insulatard (View Usage) (Dosage: ) was diagnosed with type 1 diabetes mellitus and. Location: ISRAEL , child 9 years of age, Patient had the following side effects: convulsion, hypoglycaemia, muscle spasms, product quality issue, respiratory distress. During the same period patient was treated with SULTHIAME (View Sulthiame Review and Sulthiame Label ). Patient was hospitalized.

6412136-4 | Hypoglycaemia, Muscle Spasms, Product Quality Issue, Respiratory Distress
on Sep 15, 2009 Female patient from ISRAEL , child 9 years of age, was diagnosed with type 1 diabetes mellitus and was treated with Insulatard (View Usage). After Insulatard was administered, patient had the following side effects: hypoglycaemia, muscle spasms, product quality issue, respiratory distress. Insulatard dosage: . During the same period patient was treated with SULTHIAME (View Sulthiame Review and Sulthiame Label ). Patient was hospitalized.

6115120-3 | Blood Glucose Increased, Rash, Threatened Labour
on Mar 04, 2009 Female patient from ISRAEL , 40 years of age, weighting 118.4 lb, was treated with Insulatard (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, rash (What is rash?), threatened labour. Insulatard dosage: 8 Iu, Qd. During the same period patient was treated with ELTROXIN (150 Meq, Qd) (View Eltroxin Review and Eltroxin Label ), PHENERGAN HCL (View Phenergan Hcl Review and Phenergan Hcl Label ), BETAMETHASON /00008501/ (0.1%) (View Betamethason /00008501/ Review and Betamethason /00008501/ Label ). Patient was hospitalized.

6076717-2 | Blister, Diabetes Mellitus Inadequate Control, Lip Swelling
Patient was taking Insulatard (View Usage). Patient had the following side effects: blister, diabetes mellitus inadequate control, lip swelling on Feb 05, 2009 from UNITED KINGDOM Additional patient health information: Male patient , 55 years of age, was diagnosed with type 2 diabetes mellitus and. Insulatard dosage: Unk, Unk. During the same period patient was treated with HUMAN MIXTARD 30 HM(GE) (8 Iu, Bid) (View Human Mixtard 30 Hm(ge) Review and Human Mixtard 30 Hm(ge) Label ), ENOXAPARIN SODIUM (40 Mg, Qd) (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), TAZOCIN (4.5 G, Qd) (View Tazocin Review and Tazocin Label ), RANITIDINE (50 Mg, Tid) (View Ranitidine Review and Ranitidine Label ), RAMIPRIL (5 Mg, Qd) (View Ramipril Review and Ramipril Label ), TAMSULOSIN HCL (10 Ml, Bid) (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), ATORVASTATIN (40 Mg, Qd) (View Atorvastatin Review and Atorvastatin Label ), ASPIRIN (75 Mg, Qd) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6062461-4 | Cardiac Arrest, Insomnia, Loss Of Consciousness, Restlessness
Adverse event was reported on Jan 25, 2009 by a Female patient taking Insulatard (View Usage) (Dosage: ) . Location: ISRAEL , 75 years of age, After Insulatard was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), insomnia, loss of consciousness, restlessness. During the same period patient was treated with LEVEMIR (View Levemir Review and Levemir Label ). Patient was hospitalized.

5913755-1 | Renal Impairment, Weight Increased
on Oct 01, 2008 Male patient from SWEDEN , 60 years of age, weighting 191.8 lb, was diagnosed with type 2 diabetes mellitus and was treated with Insulatard (View Usage). Patient experienced the following unwanted or unexpected effects: renal impairment, weight increased. Insulatard dosage: 10-15 Iu Qd At About 21 Oa'clock. During the same period patient was treated with GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), QUINAPRIL (View Quinapril Review and Quinapril Label ).

5840004-5 | Renal Impairment, Weight Increased
on Jul 30, 2008 Male patient from SWEDEN , 60 years of age, weighting 191.8 lb, was diagnosed with type 2 diabetes mellitus and was treated with Insulatard (View Usage). Patient had the following side effects: renal impairment, weight increased. Insulatard dosage: . During the same period patient was treated with GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), QUINAPRIL (View Quinapril Review and Quinapril Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CANDESARTAN (View Candesartan Review and Candesartan Label ), AMLOPIN /00972402/ (View Amlopin /00972402/ Review and Amlopin /00972402/ Label ).

5701874-4 | Pre-eclampsia
Patient was taking Insulatard (View Usage). After Insulatard was administered, patient had the following side effects: pre-eclampsia on Mar 31, 2008 from ROMANIA Additional patient health information: Female patient , weighting 242.5 lb, . Insulatard dosage: 24 Iu, Qd. During the same period patient was treated with ACTRAPID (50 Iu, Qd) (View Actrapid Review and Actrapid Label ).

5317452-5 | Granuloma, Panniculitis
Adverse event was reported on Apr 27, 2007 by a Male patient taking Insulatard (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: UNITED KINGDOM , 71 years of age, Patient experienced the following unwanted or unexpected effects: granuloma, panniculitis.

5290949-2 | Panniculitis
on Mar 05, 2007 Female patient from AUSTRIA , 61 years of age, was diagnosed with diabetes mellitus and was treated with Insulatard (View Usage). Patient had the following side effects: panniculitis. Insulatard dosage: . Patient was hospitalized.

5266910-0 | Panniculitis
on Mar 05, 2007 Female patient from AUSTRIA , 61 years of age, was diagnosed with diabetes mellitus and was treated with Insulatard (View Usage). After Insulatard was administered, patient had the following side effects: panniculitis. Insulatard dosage: . Patient was hospitalized.

4717250-7 | Arthralgia, Blood Pressure Systolic Increased, Dyskinesia, Gamma-glutamyltransferase Increased, Hemiplegia, Hypertonia, Muscle Contractions Involuntary, Myoclonus, Paraesthesia
Patient was taking Insulatard (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, blood pressure systolic increased, dyskinesia, gamma-glutamyltransferase increased, hemiplegia, hypertonia, muscle contractions involuntary, myoclonus, paraesthesia on Jul 07, 2005 from FRANCE Additional patient health information: Female patient , 65 years of age, . Insulatard dosage: 58 U/day. During the same period patient was treated with TOPALGIC (150 Mg, Bid) (View Topalgic Review and Topalgic Label ), ZALDIAR (4 Df, Qd) (View Zaldiar Review and Zaldiar Label ), PLAVIX (75 Mg, Qd) (View Plavix Review and Plavix Label ), RAMIPRIL (5 Mg, Qd) (View Ramipril Review and Ramipril Label ), LASIX (40 Mg, Qd) (View Lasix Review and Lasix Label ), OMEPRAZOLE (10 Mg, Qd) (View Omeprazole Review and Omeprazole Label ), VOLTAREN (View Voltaren Review and Voltaren Label ). Patient was hospitalized.

4717213-1 | Arthralgia, Blood Alkaline Phosphatase Increased, Blood Glucose Increased, Blood Pressure Systolic Increased, Dyskinesia, Gamma-glutamyltransferase Increased, Hemiplegia, Hypertonia, Muscle Contractions Involuntary
Adverse event was reported on Jul 07, 2005 by a Female patient taking Insulatard (View Usage) (Dosage: 58 U/day) . Location: FRANCE , 65 years of age, Patient had the following side effects: arthralgia, blood alkaline phosphatase increased, blood glucose increased, blood pressure systolic increased, dyskinesia, gamma-glutamyltransferase increased, hemiplegia, hypertonia, muscle contractions involuntary. During the same period patient was treated with TOPALGIC (150 Mg, Bid) (View Topalgic Review and Topalgic Label ), ZALDIAR (4 Df, Qd) (View Zaldiar Review and Zaldiar Label ), PLAVIX (75 Mg, Qd) (View Plavix Review and Plavix Label ), RAMIPRIL (5 Mg, Qd) (View Ramipril Review and Ramipril Label ), LASIX (40 Mg, Qd) (View Lasix Review and Lasix Label ), OMEPRAZOLE (10 Mg, Qd) (View Omeprazole Review and Omeprazole Label ), VOLTAREN (View Voltaren Review and Voltaren Label ). Patient was hospitalized.